about us

We are a bioinformatics and multi-omics company

We are driven forward by a vision of a future where cancer is curable.

Work with us

Scientific Advisors

David Lieberman
Oregon Health & Science University, Oregón, Portland, US

Professor of Medicine, Chief Division of Gastroenterology

Aasma Shaukat
NYU Grossman School of Medicine, New York City, US

Physician and clinical researcher. Director of Gastroenterology outcomes Research and co-director of translational research education and careers in the Clinical and Translational Science Institute.

Dr. Renee L. Williams
Associate Professor, Department of Medicine, NYU Langone, New York, US

Co-Chair of the New York Citywide Colorectal Cancer Control Coalition risk assessment and screening committee. Former chair of the Diversity, Equity, and Inclusion Committee for the American College of Gastroenterology (ACG).

Dr. Uri Ladabaum
Stanford University, Palo Alto, US

Head of Colorectal Cancer Screening Program

Dr. Samir Gupta
Associate Professor at the University of California, San Diego, California, US

Former vice chair of the National Comprehensive Cancer Network guideline committees for genetic/high-risk familial assessment and screening for colorectal cancer.

Dr. Michael Roehrl
Chief of the Department of Pathology at BIDMC, Boston, Massachusetts, US

Chief of the Department of Pathology at the Beth Israel Deaconess Medical Center (BIDMC); Specialized in diagnosing gastrointestinal diseases such as colorectal and pancreatic cancers.

Dr. Toni Castells
Clinic Hospital, Barcelona, Spain

Medical Director. Head of Colorectal Cander Screening Program.

Dr. Josep Tabernero
Vall d´Hebron Hospital, Barcelona, Spain

Director of the Institute of Oncology, ESMO President.

Dr. Thomas Rösch
Gastroenterologist, Hamburg, DE

Medical Director. Center for Endoscopy UKE Hamburg; Member of Global Clinical Trial Board Epigenomics

Dr. Siegbert Faiss
Gastroenterologist, Berlin, DE

Medical Director. Gastroenterology of Sana Klinikum Lichtenberg, Site Principal Investigator Germany; Member of Global Clinical Trial Board Epigenomics.

Dr. James Kinross
Colorectal Cancer Surgeon, London, UK

Colorectal Surgeon and Clinical Senior Lecturer in Colorectal Surgery. Member of Faculty of Medicine, Department of Surgery & Cancer at Imperial College London.


Clinical Partners





We have built a network of >100 hospitals in the U.S. and across Europe with whom we have recruited >14K samples and work with more than hundred gastrointestinal clinical teams.